Ceruloplasmin, Human Plasma

Gutteridge, J.M., and Quinlan, G.J. 1993. Biochim. Biophys. Acta1156, 144.
Krsek-Staples, J.A., and Webster, R.O. 1993. Free Radic. Biol. Med.14, 115.
Harris, E.D. 1991. Proc. Soc. Exp. Biol. Med.196, 130.

Lyophilized from 100 mM KCl, 50 mM potassium phosphate buffer, 20 mM ε-aminocaproic acid, 5 mM EDTA, pH 6.8.

Following reconstitution, aliquot and freeze (-20°C). Stock Solutions are stable for up to 4 months at -20°C.

Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Toxicity: Standard Handling (A)

Native ceruloplasmin from human plasma. Serum copper transport and iron-oxidizing protein. Plays an important role in antioxidant protection against organic and inorganic oxygen radicals generated by iron and ascorbate.